Phase I trial of iodine 131-labeled COL-1 in patients with gastrointestinal malignancies: influence of serum carcinoembryonic antigen and tumor bulk on pharmacokinetics.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples